Conference Coverage
Conference Coverage
REALITY trial supports restrictive transfusion in anemic MI
Restrictive transfusion proves more effective and less costly than liberal transfusion.
Conference Coverage
First randomized trial reassures on ACEIs, ARBs in COVID-19
The BRACE CORONA study found no difference in key outcomes between patients continuing versus stopping their medication.
Conference Coverage
HOME-PE trial clarifies which pulmonary embolism patients to treat at home
“Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides
Conference Coverage
DAPA-CKD: SGLT2 inhibitor benefit extends to chronic kidney disease without diabetes
DAPA-CKD showed that dapagliflozin helps patients with albuminuria and declining eGFR levels whether or not they have type 2 diabetes.
Conference Coverage
New ESC/EACTS guideline on atrial fibrillation
The document takes a paradigm shift away from the conventional classification of AFib and goes all in on measuring quality of care, including...
Conference Coverage
COVID-19 vaccine supply will be limited at first, ACIP says
The working group expects that from 15 to 45 million doses of vaccine will be available by the end of December, depending on which vaccine is...
Conference Coverage
Sintilimab scintillates in first-line nonsquamous NSCLC
Conference Coverage
Chemo-free management of mesothelioma on horizon
Article
Artificial intelligence matches cancer genotypes to patient phenotypes
Conference Coverage
Study: Immune checkpoint inhibitors don’t increase risk of death in cancer patients with COVID-19
The mortality rate was 8% among patients who received immune checkpoint inhibitors, which is comparable with the overall mortality rate among...